Acute Caffeine Ingestion on Futsal Performance (CAFFFUTSAL)
Effects of Acute Caffeine Ingestion on Futsal Performance in Sub-elite Players
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28223
- Universidad Francisco de Vitoria
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Sub-elite men futsal players
Exclusion Criteria:
- Intolerance to caffeine,
- Suffering from any chronic pathology or an injury in the month prior to the investigation
- Use of medicines or dietary supplements during the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo supplementation
Acute placebo supplementation
|
Gelatine capsule with placebo (Cellulose; Guinama, Valencia, Spain).
The capsule containing the treatment was ingested with 150 mL of water 60 minutes before the onset of the experiment to allow substance absorption.
|
|
Experimental: Caffeine supplementation
Acute caffeine supplementation
|
Gelatine capsule with caffeine (3 mg/kg body mass of caffeine) (Bulk Powders, London, United Kingdom).
The capsule containing the treatment was ingested with 150 mL of water 60 minutes before the onset of the experiment to allow substance absorption.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in futsal match-play demands (m/min)
Time Frame: 48-hours
|
Using a wireless inertial movement unit system
|
48-hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in maximal jump height (cm)
Time Frame: 48-hours
|
Infrared beam jump system
|
48-hours
|
|
Changes in 20-m sprint test (s)
Time Frame: 48-hours
|
Time to complete 10-m and 20-m sprints using photocell timing gates
|
48-hours
|
|
Futsal kicking velocity and accuracy test (km/h)
Time Frame: 48-hours
|
Throwing velocity using a radar gun
|
48-hours
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Alvaro L López Samanes, PhD, Universidad Francisco de Vitoria
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Universidad Francisco Vitoria
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.